websites: Bioventus and Misonix
Bioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire Misonix (press release)
The Combination Further Differentiates Bioventus’ Product Portfolio and Accelerates Its Revenue Growth
Significantly Expands TAM and Adds Considerable Scale and Scope in Spine and Lower Extremity
Enhances Surgical Solutions Vertical by Adding Minimally Invasive Ultrasonic Technologies That Improve Clinical Outcomes
Deepens Restorative Therapies Vertical by Adding Regenerative Medicine Wound Products
Bioventus and Misonix Management to Host Joint Conference Call Today at 4:30 p.m. Eastern Time
Bioventus Inc. (Nasdaq: BVS) (“Bioventus”), a global leader in innovations for active healing, and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), a provider of minimally invasive therapeutic ultrasonic technologies and regenerative medicine that enhance clinical outcomes, today announced that they have entered into a definitive agreement by which Bioventus will acquire Misonix in a cash-and-stock transaction.
Under the terms of the agreement, which has been unanimously approved by the boards of directors of both Bioventus and Misonix, Misonix stockholder...
